KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Goodwill (2018 - 2025)

Historic Goodwill for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $119.0 million.

  • Adaptive Biotechnologies' Goodwill changed 0.0% to $119.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $119.0 million for FY2024, which is 0.0% changed from last year.
  • Adaptive Biotechnologies' Goodwill amounted to $119.0 million in Q3 2025, which was down 0.0% from $119.0 million recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Goodwill high stood at $119.0 million for Q1 2021, and its period low was $119.0 million during Q1 2021.
  • Over the past 5 years, Adaptive Biotechnologies' median Goodwill value was $119.0 million (recorded in 2021), while the average stood at $119.0 million.
  • Data for Adaptive Biotechnologies' Goodwill shows a peak YoY increase of 0.0% (in 2021) and a maximum YoY decrease of 0.0% (in 2021) over the last 5 years.
  • Over the past 5 years, Adaptive Biotechnologies' Goodwill (Quarter) stood at $119.0 million in 2021, then changed by 0.0% to $119.0 million in 2022, then changed by 0.0% to $119.0 million in 2023, then changed by 0.0% to $119.0 million in 2024, then changed by 0.0% to $119.0 million in 2025.
  • Its Goodwill stands at $119.0 million for Q3 2025, versus $119.0 million for Q2 2025 and $119.0 million for Q1 2025.